299 related articles for article (PubMed ID: 11521794)
1. Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer.
Campone M; Fumoleau P; Delecroix V; Deporte-Fety R; Perrocheau G; Vernillet L; Borg-Olivier O; Louboutin JP; Bissery MC; Riva A; Azli N
Ann Oncol; 2001 Jul; 12(7):909-18. PubMed ID: 11521794
[TBL] [Abstract][Full Text] [Related]
2. Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment.
Vassilomanolakis M; Koumakis G; Demiri M; Missitzis J; Barbounis V; Efremidis AP
Cancer Invest; 2003; 21(4):497-504. PubMed ID: 14533438
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines.
Martí JL; Bueso P; Mayordomo JI; Isla MD; Saenz A; Escudero P; Murillo L; Filipovich E; Andres R; Tres A
Ann Oncol; 2001 Aug; 12(8):1061-5. PubMed ID: 11583186
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.
Ibrahim NK; Rahman Z; Valero V; Murray JL; Frye D; Hortobagyi GN
Cancer Invest; 2002; 20(1):29-37. PubMed ID: 11852999
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: a phase II study.
Rodríguez J; Calvo E; Cortes J; Santisteban M; Perez-Calvo J; Martínez-Monge R; Brugarolas A; Fernández-Hidalgo O
Breast Cancer Res Treat; 2002 Nov; 76(1):47-56. PubMed ID: 12408375
[TBL] [Abstract][Full Text] [Related]
6. Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).
Frasci G; Comella P; D'Aiuto G; Thomas R; Capasso I; Elmo M; Botti G; Cortino GR; Lapenta L; De Rosa V; Vallone P; Petrillo A; Comella G
Ann Oncol; 2000 Mar; 11(3):367-71. PubMed ID: 10811508
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel in combination chemotherapy for metastatic breast cancer.
Khayat D; Antoine E
Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-19-S13-26. PubMed ID: 9335513
[TBL] [Abstract][Full Text] [Related]
8. Clinical data and pharmacokinetics of a docetaxel-vinorelbine combination in anthracycline resistant/ relapsed metastatic breast cancer.
Airoldi M; Cattel L; Pedani F; Marchionatti S; Tagini V; Bumma C; Recalenda V
Acta Oncol; 2003; 42(3):186-94. PubMed ID: 12852694
[TBL] [Abstract][Full Text] [Related]
9. Biweekly docetaxel and vinorelbine in anthracycline-resistant metastatic breast cancer: a multicenter phase II study.
Gómez-Bernal A; Cruz JJ; García-Palomo A; Arizcun A; Pujol E; Diz P; Martín G; Fonseca E; Sánchez P; Rodríguez C; del Barco E; López Y
Am J Clin Oncol; 2003 Apr; 26(2):127-31. PubMed ID: 12714881
[TBL] [Abstract][Full Text] [Related]
10. Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.
Nolè F; Catania C; Sanna G; Imadalou K; Munzone E; Adamoli L; Longerey B; Blanchot G; Goldhirsch A
Ann Oncol; 2006 Feb; 17(2):322-9. PubMed ID: 16303864
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel combined with vinorelbine: phase I results and new study designs.
Fumoleau P; Féty R; Delecroix V; Perrocheau G; Azli N
Oncology (Williston Park); 1997 Jun; 11(6 Suppl 6):29-31. PubMed ID: 9213325
[TBL] [Abstract][Full Text] [Related]
12. Phase I-II parallel study of docetaxel on a bimonthly schedule in refractory metastatic breast carcinoma.
Gebbia V; Borsellino N; Testa A; Tirrito ML; Ferrera P; Colombo A; Mauceri G; Marrazzo A; Porretto F; Musso M
Breast Cancer Res Treat; 2003 Jan; 77(2):99-108. PubMed ID: 12602908
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer.
Lorusso V; Crucitta E; Silvestris N; Guida M; Misino A; Latorre A; De Lena M
Clin Breast Cancer; 2003 Jun; 4(2):138-41. PubMed ID: 12864942
[TBL] [Abstract][Full Text] [Related]
14. First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.
Pectasides D; Dimopoulos MA; Aravantinos G; Kalophonos HP; Papacostas P; Briasoulis E; Cogas E; Papadimitriou C; Skarlos D; Kosmidis P; Fountzilas G
Anticancer Res; 2001; 21(5):3575-80. PubMed ID: 11848526
[TBL] [Abstract][Full Text] [Related]
15. Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer.
Gómez-Bernal A; Cruz JJ; Olaverri A; Arizcun A; Martín T; Rodríguez CA; Martín G; Fonseca E; Sánchez P
Anticancer Drugs; 2005 Jan; 16(1):77-82. PubMed ID: 15613908
[TBL] [Abstract][Full Text] [Related]
16. Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.
Havlin KA; Ramirez MJ; Legler CM; Harris LN; Matulonis UA; Hohneker JA; Hayes DF; Winer EP
Cancer Chemother Pharmacol; 1999; 43(1):68-72. PubMed ID: 9923543
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel plus vinorelbine: an active regimen in metastatic breast cancer patients with prior anthracycline exposure.
Martín M; Lluch A; Casado A; Garciía Carbonero I; de Paz L; Esteban C; Insa A; Alfonso R; García-Conde J; Diaz-Rubio E
Ann Oncol; 2000 Jan; 11(1):85-9. PubMed ID: 10690393
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor.
Kornek GV; Ulrich-Pur H; Penz M; Haider K; Kwasny W; Depisch D; Kovats E; Lang F; Schneeweiss B; Scheithauer W
J Clin Oncol; 2001 Feb; 19(3):621-7. PubMed ID: 11157011
[TBL] [Abstract][Full Text] [Related]
19. Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.
Delva R; Pienkowski T; Tubiana N; Vanhoefer U; Longerey B; Douville I
Cancer Chemother Pharmacol; 2007 May; 59(6):703-9. PubMed ID: 17021821
[TBL] [Abstract][Full Text] [Related]
20. Biweekly docetaxel and vinorelbine as first-line chemotherapy in metastatic breast cancer.
Mayordomo JI; Milla A; Morales S; Yubero A; Lorenzo A; Baena JM; Modolell A; Sanz J; Illarramendi J; Garcia MJ; Machengs I; Burrilo MA; Tres A
Clin Breast Cancer; 2004 Jun; 5(2):131-5. PubMed ID: 15245617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]